Non small cell lung cancer other imaging findings: Difference between revisions
Jump to navigation
Jump to search
Line 11: | Line 11: | ||
===PET/CT=== | ===PET/CT=== | ||
*[[PET]] scanning with the tracer fluorine-18 (F-18) [[fluorodeoxyglucose]] (FDG), called FDG-PET, is widely used in the diagnosis of non-small cell lung cancer, for the following reasons:<ref name="pmid16014441">{{cite journal |vauthors=Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, Choi JY, Kwon OJ, Shim YM, Kim S |title=Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging |journal=Radiology |volume=236 |issue=3 |pages=1011–9 |year=2005 |pmid=16014441 |doi=10.1148/radiol.2363041310 |url=}}</ref> | *[[PET]] scanning with the tracer fluorine-18 (F-18) [[fluorodeoxyglucose]] (FDG), called FDG-PET, is widely used in the diagnosis of non-small cell lung cancer, for the following reasons:<ref name="pmid16014441">{{cite journal |vauthors=Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, Choi JY, Kwon OJ, Shim YM, Kim S |title=Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging |journal=Radiology |volume=236 |issue=3 |pages=1011–9 |year=2005 |pmid=16014441 |doi=10.1148/radiol.2363041310 |url=}}</ref><ref name="pmid21331927">{{cite journal |vauthors=Steinert HC |title=PET and PET-CT of lung cancer |journal=Methods Mol. Biol. |volume=727 |issue= |pages=33–51 |year=2011 |pmid=21331927 |doi=10.1007/978-1-61779-062-1_3 |url=}}</ref> | ||
:*General follow-up | :*General follow-up | ||
:*Characterization of treatment response | :*Characterization of treatment response | ||
Line 23: | Line 23: | ||
===Pulmonary angiography=== | ===Pulmonary angiography=== | ||
*On pulmonary angiography, findings of non-small cell lung cancer, include: | *On pulmonary angiography, findings of non-small cell lung cancer, include: | ||
*Evaluation of central pulmonary artery invasion | *Evaluation of central pulmonary artery invasion | ||
==Gallery== | ==Gallery== |
Revision as of 15:24, 2 March 2016
Non Small Cell Lung Cancer Microchapters |
Differentiating Non Small Cell Lung Cancer from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Non small cell lung cancer other imaging findings On the Web |
American Roentgen Ray Society Images of Non small cell lung cancer other imaging findings |
Non small cell lung cancer other imaging findings in the news |
Directions to Hospitals Treating Non small cell carcinoma of the lung |
Risk calculators and risk factors for Non small cell lung cancer other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
Other imaging findings of non-small cell lung cancer, include: PET/CT, and pulmonary angiography.[1][2]
Other Imaging Findings
PET/CT
- PET scanning with the tracer fluorine-18 (F-18) fluorodeoxyglucose (FDG), called FDG-PET, is widely used in the diagnosis of non-small cell lung cancer, for the following reasons:[1][2]
- General follow-up
- Characterization of treatment response
- Staging modality (in the risk of missing occult disease)
- On PET/CT, findings of non-small cell lung cancer, include:
- The CT scan demonstrates abnormalities such as a lung nodule or enlarged lymph nodes. Whereas, the PET scan reveals increased metabolism in structures which contain rapidly growing cancer cells
- Intense radiolabeling of tissues with high glucose uptake, such as the brain, the liver, and malignant tumor cells.
- On Gallium-67-Scan, characteristic findings of non-small cell lung cancer, include:
- Gallium uptake is mainly dependent on tumor size (limited practical value)
Pulmonary angiography
- On pulmonary angiography, findings of non-small cell lung cancer, include:
- Evaluation of central pulmonary artery invasion
Gallery
References
- ↑ 1.0 1.1 Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, Choi JY, Kwon OJ, Shim YM, Kim S (2005). "Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging". Radiology. 236 (3): 1011–9. doi:10.1148/radiol.2363041310. PMID 16014441.
- ↑ 2.0 2.1 Steinert HC (2011). "PET and PET-CT of lung cancer". Methods Mol. Biol. 727: 33–51. doi:10.1007/978-1-61779-062-1_3. PMID 21331927.